Mitch C. Hill - 15 Feb 2022 Form 4 Insider Report for Inari Medical, Inc.

Role
Chief Financial Officer
Signature
/s/ Angela Ahmad, attorney-in-fact for Mitch C. Hill
Issuer symbol
N/A
Transactions as of
15 Feb 2022
Net transactions value
-$589,816
Form type
4
Filing time
17 Feb 2022, 17:41:51 UTC
Previous filing
04 Jan 2022
Next filing
22 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Options Exercise $3,428 +7,500 +11% $0.4570* 75,288 15 Feb 2022 Direct F1
transaction NARI Common Stock Sale $259,661 -3,304 -4.4% $78.59 71,984 15 Feb 2022 Direct F1, F2
transaction NARI Common Stock Sale $333,582 -4,196 -5.8% $79.50 67,788 15 Feb 2022 Direct F1, F3
holding NARI Common Stock 1,600 15 Feb 2022 By spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NARI Stock Options (Right to buy) Options Exercise $0 -7,500 -3.1% $0.000000 236,977 15 Feb 2022 Common Stock 7,500 $0.4570 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2021
F2 This transaction was executed in multiple trades at prices ranging from $78.04 to $78.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $79.05 to $79.97. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 Options vested with respected with 25% of the underlying shares on April 30, 2020 and vest with respect to the remaining shares in 36 equal monthly installment there after.